SynthesisFrontiers in oncology2025

Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent hormone-sensitive prostate cancer: a network meta-analysis.

Armen Aprikian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.